
PharmaSecure provides technology-enabled solutions for protection against medicine counterfeiting as well as patient engagement and adherence. The company has provided IDs to 2.5 billion drug packages across 300 packaging lines for clients including five of the top ten pharmaceutical companies in India and several of the leading anti-malarial drug providers in Nigeria. PharmaSecure's proven serialization capabilities have enabled some of the leading exporters of drugs in India to meet the regulatory requirements of countries such as India, China, South Korea, Saudi Arabia and the United States. Products coded by PharmaSecure's solutions are currently being exported to more than 50 countries around the world. The company has expanded its brand protection platform to be used in other industries including FMCG, beauty & personal care, electronics, automotive, and agri-business. In addition, every month PharmaSecure engages tens of thousands of patients via text-and-voice based programs that have shown up to a 60 percent increase in adherence. It has implemented a project to measure and increase adherence for TB patients in India, supported by USAID and the Gates Foundation via a Grand Challenges in TB Control grant. PharmaSecure's CEO, Nakul Pasricha, serves as Vice President on the Governing Body of the Authentication Solution Providers' Association in India.
Primary contact Lebanon, New Hampshire, United States; Mumbai & New Delhi, India; Lagos, Nigeria
Funding 💰
Total $7.9M
Select investors Innovation Endeavors, HealthTech Capital, Gray Ghost Ventures, TSVC Capital, Tech Coast Angels, TSEF, Echoing Green, Life Science Angels
Last update: May 19, 2018